Abstract Title: currently loading...

information currently loading...

close
Loading ... please wait
timer Loading ... please wait

Free Paper Session 21: Vascular Diseases & Diabetic Retinopathy IV

12:30 - 14:00 | 08 September | Room: Amphitheatre Havane

Back to Previous

12:30The effect of duration on retinal and choroidal thicknesses in children with hypertension
S. Karaman Erdur Turkey
12:36Results of a phase 1, open-label, dose-escalation study of THR-149 in patients with diabetic macular oedema (DME)
P. Dugel United States
12:42Smartphone-based fundus imaging in diabetic retinopathy screening in low- and middle-income countries: Evaluation of four different devices
M. Wintergerst Germany
12:48Social deprivation as a risk factor for the incidence of retinal vein occlusion
T. Mahendiran United Kingdom
12:54Spectral domain optical coherence tomography (SD-OCT) based morphometric response of intravitreal dexamethasone implant for diabetic macular edema (DME)
P. Bodhankar India
13:00Spectral-domain optical coherence tomography-driven treat-and-extend regimen in patients with diabetic macular edema: 24-Month evaluation and outcome predictors
K. Hatz Switzerland
13:06Surgical treatment of diabetic maculopathy in patients with type 2 diabetes mellitus: long-term results
I. Panchenko Ukraine
13:12System of classification and automatic reference of diabetic retinopathy based on artificial intelligence in developing countries
J. Valdez Lopez Mexico
13:18Ten-year incidence and progression of diabetic retinopathy in type 1 and type 2 diabetes mellitus in France and its impact on screening strategy: the OPHDIAT study A retrospective study based on a screening program
C. Chamard France
13:24Ten-year outcomes of conventional panretinal photocoagulation in eyes with proliferative diabetic retinopathy
V. Rajendran India
13:30Treat and extend protocol with aflibercept for cystoid macular edema secondary to central retinal vein occlusion – an 18-month prospective cohort study
R. O'Day United Kingdom
13:36Treatment of diabetic macular oedema: real world outcomes from a dedicated UK injection unit
E. Linton United Kingdom
13:42Treatment outcomes achieved with the intravitreal 0.19 mg fluocinolone acetonide implant in clinical practices - Interim results from the prospective IDEAL registry study in Germany
R. Khoramnia Germany
13:48Two-year treatment outcomes of subthreshold micropulse yellow (577 nm) laser for diabetic macular edema
H. Lai Hong Kong
Back to Previous

Sign up to EURETINA


© EURETINA All rights reserved